Subtype A comprised mostly of tumors with bi-allelic NF2 loss (60/77, 78%) – these cases had either underlying NF2-related schwannomatosis or NF2 mutations detected in the tumor, all harboring chromosomal loss of 22q. This evidence concerns the gene NF2 and neoplasm.